RECUPERO, DANIELE
RECUPERO, DANIELE
SCIENZE MEDICHE
Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target.
2011-01-01 Magro G; Cataldo I; Amico P; Torrisi A; Vecchio GM; Parenti R; Asioli S; Recupero D; D'Agata V; Mucignat MT; Perris R.
Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues
2013-01-01 Anna Sapino;Margherita Goia;Daniele Recupero;Caterina Marchiò
Morgana acts as a proto-oncogene through inhibition of a ROCK-PTEN pathway.
2014-01-01 Fusella F; Ferretti R; Recupero D; Rocca S; Di Savino A; Tornillo G; Silengo L; Turco E; Cabodi S; Provero P; Pandolfi PP; Sapino A; Tarone G; Brancaccio M.
Nuclear shape in papillary thyroid carcinoma: a role for lamin B receptor?
2010-01-01 Recupero D; Annaratone L; Maletta F; Bussolati G.
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines.
2013-01-01 Recupero D;Daniele L;Marchiò C;Molinaro L;Castellano I;Cassoni P;Righi A;Montemurro F;Sismondi P;Biglia N;Viale G;Risio M;Sapino A
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Aberrant expression of TfR1/CD71 in thyroid carcinomas identifies a novel potential diagnostic marker and therapeutic target. | 2011 | Magro G; Cataldo I; Amico P; Torrisi A; Vecchio GM; Parenti R; Asioli S; Recupero D; D'Agata V; Mucignat MT; Perris R. | |
| Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues | 2013 | Anna Sapino;Margherita Goia;Daniele Recupero;Caterina Marchiò | |
| Morgana acts as a proto-oncogene through inhibition of a ROCK-PTEN pathway. | 2014 | Fusella F; Ferretti R; Recupero D; Rocca S; Di Savino A; Tornillo G; Silengo L; Turco E; Cabodi S; Provero P; Pandolfi PP; Sapino A; Tarone G; Brancaccio M. | |
| Nuclear shape in papillary thyroid carcinoma: a role for lamin B receptor? | 2010 | Recupero D; Annaratone L; Maletta F; Bussolati G. | |
| Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines. | 2013 | Recupero D;Daniele L;Marchiò C;Molinaro L;Castellano I;Cassoni P;Righi A;Montemurro F;Sismondi P;Biglia N;Viale G;Risio M;Sapino A |